Inventor · disambiguated record
Aimee Jackson
Also filed as: JACKSON AIMEE · JACKSON AIMEE L
10 granted patents·10 pending applications·21 citations·filing 2004–2022
85Inventor score
Files withMIRAGEN THERAPEUTICS INC12JACKSON AIMEE L2MERCK SHARP & DOHME2ATALANTA THERAPEUTICS INC1CLEARY MICHELE A1
Top patents by PatentIndex Score
20 records- 0190US9771585B2miR-155 inhibitors for treating cutaneous T cell lymphoma (CTCL)MIRAGEN THERAPEUTICS INC·Filed 2016·Granted Sep 26, 2017·7 cites·12 claims
- 0282US9994852B2Oligonucleotide compositions and uses thereofMIRAGEN THERAPEUTICS INC·Filed 2017·Granted Jun 12, 2018·1 cites·15 claims
- 0379US8378088B2Compositions comprising MIR34 therapeutic agents for treating cancerMERCK SHARP & DOHME·Filed 2008·Granted Feb 19, 2013·3 cites·18 claims
- 0478US8457902B2Method for selecting SIRNAs from a plurality of SIRNAs for gene silencingJACKSON AIMEE L·Filed 2011·Granted Jun 4, 2013·1 cites·13 claims
- 0578US8399248B2Methods of using MIR34 as a biomarker for TP53 functional statusCLEARY MICHELE A·Filed 2008·Granted Mar 19, 2013·5 cites·14 claims
- 0676US9885042B2miR-92 inhibitors and uses thereofMIRAGEN THERAPEUTICS INC·Filed 2016·Granted Feb 6, 2018·2 cites·19 claims
- 0776US7962316B2Method of designing siRNAs for gene silencingMERCK SHARP & DOHME·Filed 2004·Granted Jun 14, 2011·2 cites·37 claims
- 0871US2019359980A1Oligonucleotide compositions and uses thereofMIRAGEN THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0970US10316318B2Oligonucleotide compositions and uses thereofMIRAGEN THERAPEUTICS INC·Filed 2018·Granted Jun 11, 2019·0 cites·16 claims
- 1057US10280422B2MiR-92 inhibitors and uses thereofMIRAGEN THERAPEUTICS INC·Filed 2018·Granted May 7, 2019·0 cites·42 claims
- 1157US2018127750A1Mir-155 inhibitors for treating cutaneous t cell lymphoma (ctcl)MIRAGEN THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1254US2019194662A1Mir-92 inhibitors and uses thereofMIRAGEN THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1352US2024200063A1Microglial gene silencing using double-stranded sirnaATALANTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1449US2009136957A1Methods and compositions for regulating cell cycle progression via the miR-106B familyIVANOVSKA IRENA·Filed 2008·Application pending·0 cites
- 1547US8609830B2Methods and compositions for RNA interferenceJACKSON AIMEE L·Filed 2004·Granted Dec 17, 2013·0 cites·41 claims
- 1646US2020376019A1miR29 MIMICS FOR THE TREATMENT OF OCULAR FIBROSISMIRAGEN THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1745US2020276220A1Methods for treating cutaneous t-cell lymphoma (ctcl) with mir-155 inhibitorsMIRAGEN THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1841US2018161357A1Mir-155 inhibitors for treating amyotrophic lateral sclerosis (als)MIRAGEN THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1941US2009004645A1Methods for Identifying Genes that Mediate a Response of a Living Cell to an AgentROSETTA INPHARMATICS LLC·Filed 2005·Application pending·0 cites
- 2036US2018080023A1Mirna mimetics and their use in treating sensory conditionsMIRAGEN THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Aimee Jackson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →